EPO and asthma: To further dissect the activity of EPO-BM-MSCs in affecting OVA-induced asthmatic phenotype, we established an OVA-induced mouse model of asthma and performed EPO-BM-MSCs or BM-MSCs local transplantation via intratracheal administration.